Gossamer Bio Inc

NASDAQ:GOSS  
8.55
-0.15 (-1.72%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Gossamer Bio Inc Stock, NASDAQ:GOSS

3013 Science Park Road, Suite 200, San Diego, California 92121
United States of America
Phone: +1.858.684.1300
Number of Employees: 195

Description

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 25, 2015 and is headquartered in San Diego, CA.